Methodological challenges in the evaluation of prognostic factors in breast cancer
- 1 November 1998
- journal article
- review article
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 52 (1-3) , 289-303
- https://doi.org/10.1023/a:1006193704132
Abstract
Many studies are carried out in an effort to find factors that help explain the large unexplained variation in prognosis of breast cancer patients. The principles of good study design and analysis are less well appreciated for prognostic factor studies than for therapeutic trials. The oncology literature is full of results from studies of varying quality, often with conflicting findings. As a consequence, despite the large number of studies, there is still uncertainty about the importance of most prognostic factors. Few recently proposed prognostic factors for breast cancer have become widely accepted. This paper reviews the important methodological issues underlying such research. These issues are illustrated with examples from published studies and recent reviews of papers published in cancer journals. Guidelines are proposed for conducting and evaluating prognostic factor studies which should improve the quality of research in this important area.Keywords
This publication has 55 references indexed in Scilit:
- Prognostic significance of urokinase-type plasminogen activator and plasminogen activator inhibitor-1 in primary breast cancerBritish Journal of Cancer, 1998
- Relationship between cathepsin-D content and disease-free survival in node-negative breast cancer patients: a meta-analysisBritish Journal of Cancer, 1997
- Commentary: Prognostic models: clinically useful or quickly forgotten?BMJ, 1995
- Review of survival analyses published in cancer journalsBritish Journal of Cancer, 1995
- Sample size: how many patients are necessary?British Journal of Cancer, 1995
- Statistical aspects of prognostic factor studies in oncologyBritish Journal of Cancer, 1994
- Confirmation of a prognostic index in primary breast cancerBritish Journal of Cancer, 1987
- STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENTThe Lancet, 1986
- Patient subsets and variation in therapeutic efficacy.British Journal of Clinical Pharmacology, 1982
- A prognostic index in primary breast cancerBritish Journal of Cancer, 1982